Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Glucocorticoids and Mood

Edited by Edited by Lewis L. Judd (Department of Psychiatry, University of California, San Diego) and Esther Sternberg (Integrative Neural Immune Program, Section on Neuroendocrine Immunology and Behavior, NIMH, NIH, Bethesda, Maryland)
Glucocorticoids and Mood

Published: November 2009

Volume 1179

Learn More

The use of glucocorticoids is a prevalent and important treatment for patients with rheumatic disease, back pain, severe allergic reaction, and so forth by both primary care and medical specialists. Often those prescribing these powerful medications are not aware of the potential side effects and problematic sequelae. Increasing numbers of anecdotal reports, as well as a few small empirical clinical studies, associate the following with glucocorticoid treatment: mood instability, unmasking of bipolar disorders, depression, psychosis, and even suicide. The causes associated with these negative outcomes and their underlying mechanisms have, up until now, not been well understood. This volume presents a “state-of-the-science” report on glucocorticoids and mood, and the proposed mechanisms of the negative sequelae from glucocorticoid treatment.